Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intravenous Ibuprofen for Laparoscopic Bariatric Surgery

This study has been completed.
Sponsor:
Collaborators:
Cumberland Pharmaceuticals
Sagatech Electronics Inc, Alberta, Canada
Information provided by (Responsible Party):
Mindaugas Pranevicius, Jacobi Medical Center
ClinicalTrials.gov Identifier:
NCT01707251
First received: October 10, 2012
Last updated: September 2, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)